Table 2. Characteristics of the study participants.
| Drug-responsive | Drug-resistant | p-value | |
|---|---|---|---|
| (n = 121) | (n = 122) | ||
| Age (years) | |||
| At recruitment | 39.3 ± 15.1 (range, 20–84) | 39.9 ± 11.3 (range, 20–68) | 0.706 |
| At seizure onset | 25.4 ± 15.2 (range, 0–68) | 15.9 ± 10.1 (range, 0–45) | <0.001 |
| Gender (male) | 65 (53.7%) | 64 (52.5%) | 0.898 |
| Epilepsy classification | |||
| Generalized | 19 (15.7%) | 4 (3.3%) | |
| Focal | 95 (78.5%) | 118 (96.7%) | <0.001 |
| Unknown | 7 (5.8%) | 0 (0%) |